Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Sweden
Clinical Trial Center (CTC), Gothenburg Burn Centre, Linköping University Hospital, Linköping Clinical Research Unit, Lund Clinical Trial Consultants (CTC) Karolinska, Stockholm